Published online before print May 27, 2004, doi: 10.1161/01.RES.0000133680.87668.FA
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2004 American Heart Association, Inc.
Molecular Medicine |
Activated Protein C Induces Endothelial Cell Proliferation by Mitogen-Activated Protein Kinase Activation In Vitro and Angiogenesis In Vivo
From the Department of Diagnostic Medicine (M.U., K.O., H.I.), Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; Department of Cell Differentiation (Y.O., Y.I., T.S.), The Sakaguchi Laboratory, School of Medicine, Keio University, Tokyo, Japan; and the Department of Immunology (K.F.), Saga Medical School, Saga, Japan.
Correspondence to Kenji Okajima, Department of Diagnostic Medicine, Graduate School of Medical Sciences, Kumamoto University, Honjo 1-1-1, Kumamoto, 860-0811, Japan. E-mail whynot{at}kaiju.medic.kumamoto-u.ac.jp
Activated protein C (APC), a natural anticoagulant, has recently been demonstrated to activate the mitogen-activated protein kinase (MAPK) pathway in endothelial cells in vitro. Because the MAPK pathway is implicated in endothelial cell proliferation, it is possible that APC induces endothelial cell proliferation, thereby causing angiogenesis. We examined this possibility in the present study. APC activated the MAPK pathway, increased DNA synthesis, and induced proliferation in cultured human umbilical vein endothelial cells dependent on its serine protease activity. Antibody against the endothelial protein C receptor (EPCR) inhibited these events. Early activation of the MAPK pathway was inhibited by an antibody against protease-activated receptor-1, whereas neither late and complete activation of the MAPK pathway nor endothelial cell proliferation were inhibited by this antibody. APC activated endothelial nitric oxide synthase (eNOS) via phosphatidylinositol 3-kinase–dependent phosphorylation, followed by activation of protein kinase G, suggesting that APC bound to EPCR might activate the endothelial MAPK pathway by a mechanism similar to that of VEGF. APC induced morphogenetic changes resembling tube-like structures of endothelial cells, whereas DIP-APC did not. When applied topically to the mouse cornea, APC clearly induced angiogenesis in wild-type mice, but not in eNOS knockout mice. These in vitro events induced by APC might at least partly explain the angiogenic activity in vivo. This angiogenic activity of APC might contribute to maintain proper microcirculation in addition to its antithrombotic activity.
Key Words: angiogenesis • activated protein C • endothelial protein C receptor • protease-activated receptor-1 • mitogen-activated protein kinase
This article has been cited by other articles:
 |
|
 |
|
  G. L. Van Sluis, T. M.H. Niers, C. T. Esmon, W. Tigchelaar, D. J. Richel, H. R. Buller, C. J.F. Van Noorden, and C. A. Spek Endogenous activated protein C limits cancer cell extravasation through sphingosine-1-phosphate receptor 1-mediated vascular endothelial barrier enhancement Blood, August 27, 2009; 114(9): 1968 - 1973. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.-C. Ho, S.-L. Chen, Y.-C. Yang, T.-H. Lo, J.-W. Hsieh, H.-C. Cheng, and Y.-P. Tsao Cytosolic phospholipase A2-{alpha} is an early apoptotic activator in PEDF-induced endothelial cell apoptosis Am J Physiol Cell Physiol, February 1, 2009; 296(2): C273 - C284. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. V. Yang, Y. Banerjee, J. A. Fernandez, H. Deguchi, X. Xu, L. O. Mosnier, Rolf. T. Urbanus, P. G. de Groot, T. C. White-Adams, O. J. T. McCarty, et al. Activated protein C ligation of ApoER2 (LRP8) causes Dab1-dependent signaling in U937 cells PNAS, January 6, 2009; 106(1): 274 - 279. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Thiyagarajan, J. A. Fernandez, S. M. Lane, J. H. Griffin, and B. V. Zlokovic Activated Protein C Promotes Neovascularization and Neurogenesis in Postischemic Brain via Protease-Activated Receptor 1 J. Neurosci., November 26, 2008; 28(48): 12788 - 12797. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. J. Calvert, L. G. Chicoine, Y. Liu, and L. D. Nelin Deficiency of mitogen-activated protein kinase phosphatase-1 results in iNOS-mediated hypotension in response to low-dose endotoxin Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1621 - H1629. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Riewald and R. A. Schuepbach Protective Signaling Pathways of Activated Protein C in Endothelial Cells Arterioscler Thromb Vasc Biol, January 1, 2008; 28(1): 1 - 3. [Full Text] [PDF]
|
|
|
|
|
|
L. A. O'Brien, M. A. Richardson, S. F. Mehrbod, D. T. Berg, B. Gerlitz, A. Gupta, and B. W. Grinnell Activated Protein C Decreases Tumor Necrosis Factor Related Apoptosis-Inducing Ligand by an EPCR- Independent Mechanism Involving Egr-1/Erk-1/2 Activation Arterioscler Thromb Vasc Biol, December 1, 2007; 27(12): 2634 - 2641. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-S. Li, L. Wu, and J. A. Fernandez The Endothelial Protein C Receptor in Vascular Smooth Muscle Cells For Good or Bad? Circ. Res., May 25, 2007; 100(10): e86 - e86. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Xue, D. Campbell, and C. J. Jackson Protein C Is an Autocrine Growth Factor for Human Skin Keratinocytes J. Biol. Chem., May 4, 2007; 282(18): 13610 - 13616. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. O. Mosnier, B. V. Zlokovic, and J. H. Griffin The cytoprotective protein C pathway Blood, April 15, 2007; 109(8): 3161 - 3172. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Bretschneider, B. Uzonyi, A.-A. Weber, J. W. Fischer, R. Pape, K. Lotzer, and K. Schror Human Vascular Smooth Muscle Cells Express Functionally Active Endothelial Cell Protein C Receptor Circ. Res., February 2, 2007; 100(2): 255 - 262. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Feistritzer, R. A. Schuepbach, L. O. Mosnier, L. A. Bush, E. Di Cera, J. H. Griffin, and M. Riewald Protective Signaling by Activated Protein C Is Mechanistically Linked to Protein C Activation on Endothelial Cells J. Biol. Chem., July 21, 2006; 281(29): 20077 - 20084. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. B. Balazs, A. J. Fabian, C. T. Esmon, and R. C. Mulligan Endothelial protein C receptor (CD201) explicitly identifies hematopoietic stem cells in murine bone marrow Blood, March 15, 2006; 107(6): 2317 - 2321. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. T. Berg, B. Gerlitz, G. R. Sharma, M. A. Richardson, E. J. Stephens, R. L. Grubbs, K. C. Holmes, K. Fynboe, D. Montani, M. S. Cramer, et al. FoxA2 Involvement in Suppression of Protein C, an Outcome Predictor in Experimental Sepsis Clin. Vaccine Immunol., March 1, 2006; 13(3): 426 - 432. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Kukidome, T. Nishikawa, K. Sonoda, K. Imoto, K. Fujisawa, M. Yano, H. Motoshima, T. Taguchi, T. Matsumura, and E. Araki Activation of AMP-Activated Protein Kinase Reduces Hyperglycemia-Induced Mitochondrial Reactive Oxygen Species Production and Promotes Mitochondrial Biogenesis in Human Umbilical Vein Endothelial Cells Diabetes, January 1, 2006; 55(1): 120 - 127. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. David-Dufilho, E. M.-V. Brussel, G. Topal, L. Walch, A. Brunet, and F. Rendu Endothelial Thrombomodulin Induces Ca2+ Signals and Nitric Oxide Synthesis through Epidermal Growth Factor Receptor Kinase and Calmodulin Kinase II J. Biol. Chem., October 28, 2005; 280(43): 35999 - 36006. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Riewald and W. Ruf Protease-activated Receptor-1 Signaling by Activated Protein C in Cytokine-perturbed Endothelial Cells Is Distinct from Thrombin Signaling J. Biol. Chem., May 20, 2005; 280(20): 19808 - 19814. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Ludeman, H. Kataoka, Y. Srinivasan, N. L. Esmon, C. T. Esmon, and S. R. Coughlin PAR1 Cleavage and Signaling in Response to Activated Protein C and Thrombin J. Biol. Chem., April 1, 2005; 280(13): 13122 - 13128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Iwaki, D. T. Cruz, J. A. Martin, and F. J. Castellino A cardioprotective role for the endothelial protein C receptor in lipopolysaccharide-induced endotoxemia in the mouse Blood, March 15, 2005; 105(6): 2364 - 2371. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Chen, M. Guo, D. Wygle, P. A. Edwards, J. R. Falck, R. J. Roman, and A. G. Scicli Inhibitors of Cytochrome P450 4A Suppress Angiogenic Responses Am. J. Pathol., February 1, 2005; 166(2): 615 - 624. [Abstract] [Full Text] [PDF]
|
|